239 results
Early diagnosis and lifetime management of valvular heart disease: new tools and treatment paradigms
25 Nov 2024 – From PCR London Valves 2024
What if we could detect and treat progressive heart valve disease before it worsens? Dives into the latest breakthroughs with this video, showcasing how emerging technologies and innovative strategies are transforming patient outcomes.
Gain insights from the RECOVERY, AVATAR, EVOLVED and EARLY TAVR trials, and discover how AI,...
Rapid-Fire - Rare and unusual (Part 2)
25 Nov 2024 – From PCR London Valves 2024
Delve into a series of rare and unusual cases selected from the PCR London Valves 2024 Clinical Cases submissions. Explore a wide range of complex interventional scenarios, including edge-to-edge strategy failure, a challenging case of LAA occlusion, a large aortic pseudoaneurysm, and more. This rapid-fire session...
Patient-driven strategies to improve women's experience of heart valve disease: better partnerships for better outcomes
25 Nov 2024 – From PCR London Valves 2024
Curious about how to improve care for women with heart valve disease?
Join this session to explore patient-centred strategies, gain insights from the latest SMART data and dive into the RHEIA trial. You’ll learn how to integrate shared decision-making and strengthen Heart Team partnerships to deliver better outcomes...
Featured Cases - Congenital heart disease and younger patients
25 Nov 2024 – From PCR London Valves 2024
Delve into this featured session from PCR London Valves 2024, showcasing selected clinical cases focused on congenital heart disease and younger patients. Explore innovative approaches, such as TEER for common aortic valve in complex congenital heart disease, transcatheter double valve-in-valve replacement in right heart disease, and...
Featured cases - Paravalvular leak closure
24 Nov 2024 – From PCR London Valves 2024
Dive into a captivating session showcasing selected PCR London Valves 2024 clinical cases on paravalvular leak closure. Witness the use of a hybrid approach for aortic paravalvular leaks, the management of infective endocarditis complications, and the percutaneous treatment of complex malpositioned valves. Explore interventions to address...
Featured cases - Combined valve interventions (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a captivating collection of featured cases showcasing the art of combined valve interventions. Witness precision and planning in dual-valve symphony, innovative solutions for complex mitral annular calcification, and unexpected twists where the results defy expectations. Delve into transcatheter approaches for aortic bioprosthesis degeneration, mitral repair...
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
Rapid-fire - Transcatheter solutions for rare complications
24 Nov 2024 – From PCR London Valves 2024
Prepare to be captivated by a rapid-fire session showcasing transcatheter solutions for rare and complex cardiovascular complications. Witness the percutaneous closure of a right ventricular pseudo-aneurysm, the treatment of a VSD complicating myocardial infarction, and the management of iatrogenic left ventricular pseudo-aneurysms. Explore innovative approaches to...
Rapid-Fire - Rare and unusual (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of rare and unusual interventional cardiology cases. Witness the first known case of dual valve-in-valve replacement in caval valve implantation, the management of device-related allergic reactions, and the treatment of left atrial thrombi associated with appendage occlusion devices. Explore solutions...
Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial
16 Nov 2024
Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.
Author
